(-)-demecolcine decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Demecolcine results in decreased expression of EPB41L5 mRNA CTD PMID:23649840 17beta-estradiol decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Estradiol results in decreased expression of EPB41L5 mRNA CTD PMID:31614463 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Epb41l5 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Epb41l5 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Epb41l5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of EPB41L5 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of EPB41L5 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of EPB41L5 mRNA CTD PMID:21215274 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Epb41l5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of EPB41L5 mRNA CTD PMID:19465110 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of EPB41L5 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of EPB41L5 mRNA CTD PMID:21346803 4,4'-diaminodiphenylmethane increases expression ISO Epb41l5 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of EPB41L5 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases methylation ISO EPB41L5 (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of EPB41L5 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression ISO Epb41l5 (Mus musculus) 6480464 Fenretinide results in increased expression of EPB41L5 mRNA CTD PMID:28973697 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of EPB41L5 mRNA CTD PMID:24780913 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of EPB41L5 mRNA CTD PMID:28959563 all-trans-retinoic acid increases expression ISO EPB41L5 (Homo sapiens) 6480464 Tretinoin results in increased expression of EPB41L5 mRNA CTD PMID:21934132 and PMID:23724009 all-trans-retinoic acid decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of EPB41L5 mRNA CTD PMID:33167477 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of EPB41L5 mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO EPB41L5 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of EPB41L5 mRNA CTD PMID:24449571 arsane increases methylation ISO EPB41L5 (Homo sapiens) 6480464 Arsenic results in increased methylation of EPB41L5 promoter CTD PMID:21291286 arsenic atom increases methylation ISO EPB41L5 (Homo sapiens) 6480464 Arsenic results in increased methylation of EPB41L5 promoter CTD PMID:21291286 arsenite(3-) multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to EPB41L5 mRNA] CTD PMID:32406909 belinostat increases expression ISO EPB41L5 (Homo sapiens) 6480464 belinostat results in increased expression of EPB41L5 mRNA CTD PMID:26272509 benzo[a]pyrene decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of EPB41L5 mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases methylation ISO EPB41L5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of EPB41L5 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO Epb41l5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of EPB41L5 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of EPB41L5 mRNA CTD PMID:21839799 benzo[a]pyrene multiple interactions ISO Epb41l5 (Mus musculus) 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of EPB41L5 mRNA] CTD PMID:22228805 benzo[a]pyrene diol epoxide I affects expression ISO EPB41L5 (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 Benzo[ghi]perylene increases expression ISO Epb41l5 (Mus musculus) 6480464 1 and 12-benzoperylene results in increased expression of EPB41L5 mRNA CTD PMID:26377693 bisphenol A decreases expression ISO Epb41l5 (Mus musculus) 6480464 bisphenol A results in decreased expression of EPB41L5 mRNA CTD PMID:26063408 bisphenol A decreases methylation ISO EPB41L5 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of EPB41L5 gene CTD PMID:31601247 bisphenol A decreases expression ISO EPB41L5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of EPB41L5 mRNA CTD PMID:33670352 bisphenol A affects methylation ISO Epb41l5 (Mus musculus) 6480464 bisphenol A affects the methylation of EPB41L5 promoter CTD PMID:27334623 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of EPB41L5 mRNA CTD PMID:25181051 and PMID:34947998 butanal decreases expression ISO EPB41L5 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of EPB41L5 mRNA CTD PMID:26079696 caffeine increases phosphorylation ISO EPB41L5 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of EPB41L5 protein CTD PMID:35688186 carbon nanotube affects expression ISO Epb41l5 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of EPB41L5 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO Epb41l5 (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of EPB41L5 mRNA CTD PMID:25554681 chloroprene decreases expression ISO Epb41l5 (Mus musculus) 6480464 Chloroprene results in decreased expression of EPB41L5 mRNA CTD PMID:23125180 cisplatin increases phosphorylation ISO Epb41l5 (Mus musculus) 6480464 Cisplatin results in increased phosphorylation of EPB41L5 protein CTD PMID:22006019 copper atom multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of EPB41L5 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of EPB41L5 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of EPB41L5 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO EPB41L5 (Homo sapiens) 6480464 coumarin results in increased phosphorylation of EPB41L5 protein CTD PMID:35688186 coumestrol decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Coumestrol results in decreased expression of EPB41L5 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 dibenz[a,h]anthracene increases expression ISO Epb41l5 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 dicrotophos decreases expression ISO EPB41L5 (Homo sapiens) 6480464 dicrotophos results in decreased expression of EPB41L5 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Enterolactone multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPB41L5 mRNA CTD PMID:19167446 entinostat multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L5 mRNA CTD PMID:27188386 entinostat increases expression ISO EPB41L5 (Homo sapiens) 6480464 entinostat results in increased expression of EPB41L5 mRNA CTD PMID:26272509 epoxiconazole decreases expression ISO Epb41l5 (Mus musculus) 6480464 epoxiconazole results in decreased expression of EPB41L5 mRNA CTD PMID:35436446 ethanol increases expression ISO Epb41l5 (Mus musculus) 6480464 Ethanol results in increased expression of EPB41L5 mRNA CTD PMID:30319688 formaldehyde decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of EPB41L5 mRNA CTD PMID:23649840 geldanamycin increases expression ISO EPB41L5 (Homo sapiens) 6480464 geldanamycin results in increased expression of EPB41L5 mRNA CTD PMID:26705709 hydrogen peroxide affects expression ISO EPB41L5 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of EPB41L5 mRNA CTD PMID:20044591 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of EPB41L5 mRNA CTD PMID:24136188 mercury dibromide increases expression ISO EPB41L5 (Homo sapiens) 6480464 mercuric bromide results in increased expression of EPB41L5 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L5 mRNA CTD PMID:27188386 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of EPB41L5 mRNA CTD PMID:30467583 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of EPB41L5 gene CTD PMID:33148267 N-ethyl-N-nitrosourea increases mutagenesis ISO Epb41l5 (Mus musculus) 6480464 Ethylnitrosourea results in increased mutagenesis of EPB41L5 gene CTD PMID:15755804 nickel atom decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Nickel results in decreased expression of EPB41L5 mRNA CTD PMID:25583101 ozone multiple interactions ISO Epb41l5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of EPB41L5 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of EPB41L5 mRNA CTD PMID:34911549 panobinostat increases expression ISO EPB41L5 (Homo sapiens) 6480464 panobinostat results in increased expression of EPB41L5 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L5 mRNA CTD PMID:27188386 paracetamol increases expression ISO EPB41L5 (Homo sapiens) 6480464 Acetaminophen results in increased expression of EPB41L5 mRNA CTD PMID:21420995 and PMID:22230336 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of EPB41L5 mRNA CTD PMID:32680482 PCB138 multiple interactions ISO Epb41l5 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of EPB41L5 gene CTD PMID:33148267 phenylmercury acetate affects expression ISO EPB41L5 (Homo sapiens) 6480464 Phenylmercuric Acetate affects the expression of EPB41L5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 pirinixic acid multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of EPB41L5 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO Epb41l5 (Mus musculus) 6480464 pirinixic acid results in increased expression of EPB41L5 mRNA CTD PMID:17426115 and PMID:20813756 pirinixic acid decreases expression ISO Epb41l5 (Mus musculus) 6480464 pirinixic acid results in decreased expression of EPB41L5 mRNA CTD PMID:18445702 potassium chromate increases expression ISO EPB41L5 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of EPB41L5 mRNA CTD PMID:22714537 progesterone decreases expression ISO Epb41l5 (Mus musculus) 6480464 Progesterone results in decreased expression of EPB41L5 mRNA CTD PMID:22238285 quercetin decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Quercetin results in decreased expression of EPB41L5 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of EPB41L5 mRNA CTD PMID:19167446 SB 431542 increases expression ISO EPB41L5 (Homo sapiens) 6480464 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of EPB41L5 protein CTD PMID:25670856 SB 431542 multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of EPB41L5 mRNA CTD PMID:25895662 silver atom decreases expression ISO Epb41l5 (Mus musculus) 6480464 Silver results in decreased expression of EPB41L5 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Epb41l5 (Mus musculus) 6480464 Silver results in decreased expression of EPB41L5 mRNA CTD PMID:27131904 sodium arsenate increases expression ISO Epb41l5 (Mus musculus) 6480464 sodium arsenate results in increased expression of EPB41L5 mRNA CTD PMID:30953684 sodium arsenite decreases expression ISO EPB41L5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of EPB41L5 mRNA CTD PMID:29301061 and PMID:34032870 sunitinib increases expression ISO EPB41L5 (Homo sapiens) 6480464 Sunitinib results in increased expression of EPB41L5 mRNA CTD PMID:31533062 temozolomide increases expression ISO EPB41L5 (Homo sapiens) 6480464 Temozolomide results in increased expression of EPB41L5 mRNA CTD PMID:31758290 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of EPB41L5 mRNA CTD PMID:31150632 thimerosal decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Thimerosal results in decreased expression of EPB41L5 mRNA CTD PMID:27188386 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of EPB41L5 mRNA CTD PMID:34492290 trichostatin A decreases expression ISO EPB41L5 (Homo sapiens) 6480464 trichostatin A results in decreased expression of EPB41L5 mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 trichostatin A affects expression ISO EPB41L5 (Homo sapiens) 6480464 trichostatin A affects the expression of EPB41L5 mRNA CTD PMID:26272509 and PMID:28542535 trichostatin A increases expression ISO EPB41L5 (Homo sapiens) 6480464 trichostatin A results in increased expression of EPB41L5 mRNA CTD PMID:24935251 urethane increases expression ISO EPB41L5 (Homo sapiens) 6480464 Urethane results in increased expression of EPB41L5 mRNA CTD PMID:28818685 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of EPB41L5 mRNA CTD PMID:24136188 valproic acid decreases expression ISO EPB41L5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of EPB41L5 mRNA CTD PMID:23179753 and PMID:24935251 valproic acid increases expression ISO EPB41L5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of EPB41L5 mRNA CTD PMID:24383497 more ... valproic acid decreases methylation ISO EPB41L5 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of EPB41L5 gene CTD PMID:29154799 valproic acid affects expression ISO EPB41L5 (Homo sapiens) 6480464 Valproic Acid affects the expression of EPB41L5 mRNA CTD PMID:25979313 and PMID:26272509 valproic acid multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 vorinostat multiple interactions ISO EPB41L5 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPB41L5 mRNA CTD PMID:27188386 vorinostat decreases expression ISO EPB41L5 (Homo sapiens) 6480464 vorinostat results in decreased expression of EPB41L5 mRNA CTD PMID:27188386 vorinostat increases expression ISO EPB41L5 (Homo sapiens) 6480464 vorinostat results in increased expression of EPB41L5 mRNA CTD PMID:26272509